Sign in

CIK 0001936258 · Large accelerated filer

NewAmsterdam Pharma Co N.V.

Sign in to watch
Ticker
NAMS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Netherlands
Entity type
operating
Phone
35 206 2971
Business address
GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
Former names
NewAmsterdam Pharma Co B.V.

Securities

  • NAMS Ordinary Shares Nasdaq
  • NAMSW Warrant Nasdaq
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. F-4/A Deal Registration of Securities, Foreign Private Issuers, Business Combinations
  3. 425 Deal Prospectus/Communication re Business Combination
  4. UPLOAD Other SEC-generated Letter
  5. 425 Deal Prospectus/Communication re Business Combination
  6. 425 Deal Prospectus/Communication re Business Combination
  7. 425 Deal Prospectus/Communication re Business Combination
  8. 425 Deal Prospectus/Communication re Business Combination
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. F-4/A Deal Registration of Securities, Foreign Private Issuers, Business Combinations
  11. 425 Deal Prospectus/Communication re Business Combination
  12. 425 Deal Prospectus/Communication re Business Combination
  13. UPLOAD Other SEC-generated Letter
  14. 425 Deal Prospectus/Communication re Business Combination
  15. 425 Deal Prospectus/Communication re Business Combination
  16. 425 Deal Prospectus/Communication re Business Combination
  17. 425 Deal Prospectus/Communication re Business Combination
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. F-4/A Deal Registration of Securities, Foreign Private Issuers, Business Combinations
  20. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit

Page 20 of 21 · 415 filings